KL003 cell injection

· Kanglin Biotechnology (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KL003 cell injection, covering 2025-03-10 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease [NA]